<DOC>
	<DOCNO>NCT01731873</DOCNO>
	<brief_summary>The purpose research study identify factor gene ( nucleic acid material determines makeup human body ) may associate patient respond pain medication , like morphine , call opioids . Though pain medicine use everyday , patient bad reaction use , like breathe problem , sedation , etc . It possible completely predict pain medicine 'right ' child . The investigator want study factor may associate pain sensitivity , pain medicine requirement surgery side-effects . The investigator expect information obtain research study help u develop effective , safe , tailor treatment option future .</brief_summary>
	<brief_title>Patient Controlled Analgesia Pharmacogenetic Study</brief_title>
	<detailed_description>Opioids mainstay treatment postoperative pain child . Experience dictate opioids narrow therapeutic index large inter-patient variability response . This lead serious side effect like respiratory depression 50 % child undergo invasive surgery , fatal . Moreover , two-thirds inter-individual variability response opioids result genetic variation variability pain perception well response pain medicine . Much inter-individual variability response opioids follow surgical procedure explain single nucleotide polymorphism ( SNPs ) subset gene encode protein involve pain perception , opioid transport/metabolism ( pharmacokinetics ) opioid receptor signaling ( pharmacodynamics ) . It evident particular child susceptible suffer side effect inadequate pain relief opioids . Identifying genetic non-genetic predictor susceptibility vital safe effective analgesia child . This critical knowledge gap medical literature significantly impact pediatric pain management . The investigator ' central hypothesis specific genetic polymorphism gene involve pain perception , opioid transport opioid receptor signal pathway contribute significantly pain sensitivity , opioid side-effects analgesic efficacy child . The choice dose opioids thus far largely empirical , frequent need switch opioids alter dos due inherent difference individual . By study , investigator hope determine 'right ' dos 'right ' opioids optimize safe postoperative analgesia child . The investigator ' long term goal develop effective , safer tailor pediatric opioid analgesia , contribute well understand underlying genetic basis variation sensitivity pain , pain relief , development adverse effect extend use postoperative intravenous opioids , child .</detailed_description>
	<criteria>Children include age 18 year Scheduled surgery require opioids PCA PCA proxy postoperative pain relief Children history liver renal dysfunction Patients severe respiratory problem Children preoperative pain require opioids Children additional infusion like ketamine / lidocaine dexmedetomidine peri operatively Children BMI &gt; 30</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>postoperative</keyword>
	<keyword>pediatric</keyword>
	<keyword>pharmacogenetic</keyword>
	<keyword>opioid</keyword>
	<keyword>perioperative</keyword>
	<keyword>respiratory depression</keyword>
</DOC>